Hwangbo, H., Kim, M. Y., Ji, S. Y., Kim, S. Y., Lee, H., Kim, G., . . . Choi, Y. H. (2020). Auranofin Attenuates Non-Alcoholic Fatty Liver Disease by Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro. Antioxidants (Basel).
استشهاد بنمط شيكاغوHwangbo, Hyun, et al. "Auranofin Attenuates Non-Alcoholic Fatty Liver Disease By Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro." Antioxidants (Basel) 2020.
MLA استشهادHwangbo, Hyun, et al. "Auranofin Attenuates Non-Alcoholic Fatty Liver Disease By Suppressing Lipid Accumulation and NLRP3 Inflammasome-Mediated Hepatic Inflammation In Vivo and In Vitro." Antioxidants (Basel) 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.